PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1057407
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1057407
The global Bioprocess Containers market was valued at USD 3,100.6 million in 2020, growing with 27.1% CAGR during the forecast period, 2021-2027.
Bioprocess containers are readily available, flexible container solutions used in life sciences and biopharmaceutical industries to handle sterile fluids during production operations. These containers are thought to be a good alternative to stainless steel containers because they are less expensive. Bioprocess containers components are employed in a wide range of high-performance solutions at every stage of the manufacturing process.
Due to factors such as increased demand for biologics and increased manufacture of vaccines utilizing single-use disposable technologies, the global bioprocess containers market is predicted to develop significantly over the forecast period. In addition, the cost-effectiveness and long-term viability of single-use bioprocess technologies are driving the growth of the bioprocess containers market. Furthermore, the market's expansion is aided by a lesser chance of cross-contamination. However, significant difficulties connected with soluble and easily retrievable bioprocess containers, the installation of severe regulatory policies toward bioprocess container manufacturing practice, and high instrument costs are all important roadblocks to the market's growth. The introduction of new pharmaceuticals into the market, on the other hand, is expected to generate profitable chances.
COVID-19 is an identified novel coronavirus that causes an infectious sickness. COVID-19, which was mostly unknown until the outbreak in Wuhan, China, in December 2019, has subsequently evolved from a localized issue to a worldwide pandemic. With the WHO declaring the virus's breakout a pandemic, a number of recognized pharmaceutical businesses, as well as bioprocess container manufacturers, have come up to produce therapies and vaccinations to combat the unique coronavirus infection. For example, Pall Corporation (US) purchased Pall-Austar Lifesciences Limited (China), a joint venture between Pall and the Austar Group, in March 2021. Pall's production capacity was increased as a result of this purchase in China, which was large to meet the need for single-use technology supply chains.
The Bioprocess Containers market is segmented on the basis of Type, Application, Sales Channel, application, and region.
Over the forecast period, the 2D bioprocess containers segment is expected to account for the biggest share of market revenue. This supremacy stems from their capacity to accelerate the existing biopharmaceutical manufacturing process while also assisting with storage, media preparation, and fluid management. Due to the growing use of these systems with lower labor costs and quicker processing utilizing these containers, the 3D bioprocess containers sector is expected to develop at the fastest pace throughout the projected period, driving the market forward.
The upstream process segment is expected to have the biggest revenue share over the projected period, according to the application. The widespread usage of bioprocess containers in various processes, notably during mixing, fermentation, and culture medium processing, contributes to the growth of the worldwide bioprocess container market.
The biopharmaceutical businesses segment is expected to hold significant market share during the forecast period, owing to the price of single-use bioprocess container systems, which minimize utility requirements and reduce cleaning validation efforts, resulting in a reduction in overall production costs. As a result, biopharmaceutical businesses contribute to market expansion.
Throughout the projected period, North America is likely to lead the entire bioprocess container market. This dominance is mostly due to the increasing demand for biopharmaceuticals in the United States as a result of the growing elderly population and enhanced healthcare infrastructure. Furthermore, the presence of prominent companies focused on research activities, as well as significant expenditures in health care by companies located in the United States, adds to the market's remarkable worldwide growth.
The key players include Merck KGaA, General Electric Company, Sartorius AG, Thermo Fisher Scientific, Lonza, Fluid Controls Pvt. Ltd., Danaher Corporation, Rim Bio Inc., Fenner Group Holdings Limited, and Meissner Filtration Products, Inc.
Merck KGaA spent USD 30 million in March 2021 at its Life Science Center in Molsheim, France, to add a single-use assembly manufacturing facility. With this development, the business is speeding up its aspirations to expand single-use technology throughout Europe, which is used to make COVID-19 vaccines and other life-saving medications.
The scope of this report covers the market by its major segments, which include as follows:
List of Tables
List of Figures